Table 2.
SRPX2 Expression | |||
---|---|---|---|
Parameters | − (%) | + (%) | p Value * |
Gender | |||
Male | 61 (68.5) | 28 (31.5) | |
Female | 55 (76.4) | 17 (23.6) | 0.2938 |
Age | |||
<65 | 54 (75) | 18 (25) | |
>65 | 62 (69.7) | 27 (30.3) | 0.4844 |
Site | |||
Tongue | 60 (66.7) | 30 (33.3) | |
Gingiva | 42 (80.8) | 10 (19.2) | |
Buccal mucosa | 7 (70) | 3 (30) | |
Other | 7 (77.8) | 2 (22.2) | 0.3305 |
Histology | |||
Well | 57 (75) | 19 (25) | |
Moderately, Poorly | 59 (69.4) | 26 (30.6) | 0.4839 |
T classification | |||
T1-T3 | 81 (74.3) | 28 (25.7) | |
T4 | 35 (67.3) | 17 (32.7) | 0.3554 |
Clinical stage | |||
I-II | 79 (75.2) | 26 (24.8) | |
IV | 37 (66.1) | 19 (33.9) | 0.2688 |
Nodal metastasis | |||
Negative | 91 (77.1) | 27 (22.9) | |
Positive | 25 (58.1) | 18 (41.9) | 0.0280 |
MVD | 25.128 ± 14.741 | 33.109 ± 23.841 | 0.0111 |
LVD | 20.245 ± 13.894 | 27.136 ± 19.583 | 0.0129 |
The relationship between expression of sushi repeat containing protein X linked-2 (SRPX2) and each factor was calculated by Fisher’s exact test or chi-square test. The differences of the microvessel density (MVD) and lymphovessel density (LVD) among groups were analyzed by unpaired parametric t-test. MVD and LVD were Means ± S.D. (standard deviation), each S.D. was less than 10% in all cases. T classification and clinical stage were classified according to the TNM classification.* p value < 0.05 was regarded as statistically significant.